Russia’s Binnopharm Brings In Mabwell’s Adalimumab, Denosumab Biosimilars

Humira Biosimilar Approved In China; Prolia/Xgeva Rivals Pending Approvals

 
• By Dean Rudge
  
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products